Improving our ability to remove these tumors

“In our pilot study, SPY has helped identify the boundaries of renal tumors on several occasions, improving our ability to remove these tumors with negative margins during partial nephrectomy.”

Edward M. Messing, MD, FACS
Chair, Department of Urology
W.W. Scott Professor of Urology
Urologic Oncology
Strong Memorial Hospital
University of Rochester Medical Center
Rochester, New York
Dragan Golijanin, MD
Urology Department
Strong Memorial Hospital
University of Rochester Medical Center
Rochester, New York